Fluquinconazole

Fluquinconazole

SCHEMBL3685935

O=c1c2cc(F)ccc2nc(-n2cncn2)n1-c1ccc(Cl)cc1Cl.O=c1c2cc(F)ccc2nc(-n2cncn2)n1-c1ccc(Cl)cc1Cl

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 2/20 0.43
IDO2 Q6ZQW0 2/20 0.43
IDO1 P14902 1/20 0.43
MPI P34949 1/20 0.40
PHOSPHO1 Q8TCT1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluquinconazole SCHEMBL29422244 1.00 TDO2 (0.43) TDO2IDO2IDO1MPIPHOSPHO1
Fluquinconazole SCHEMBL21234 1.00 TDO2 (0.43) TDO2IDO2IDO1MPIPHOSPHO1
Fluquinconazole SCHEMBL29488449 1.00 TDO2 (0.43) TDO2IDO2IDO1MPIPHOSPHO1
SCHEMBL10518452 0.92 KDM4E (0.39) IDO1
Fluquinconazole SCHEMBL23174822 0.91 IDO1 (0.37) TDO2IDO2IDO1MPIPHOSPHO1
SCHEMBL16864750 0.90 TDO2 (0.44) TDO2IDO2IDO1
SCHEMBL10516150 0.88 KDM4E (0.37) IDO1
SCHEMBL10516516 0.88 MEN1 (0.42) TDO2IDO2IDO1
Fluquinconazole SCHEMBL2727515 0.87 CYP3A4 (0.36)
SCHEMBL15756732 0.86 APAF1 (0.49) TDO2IDO2IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100305161-A1 COMBINATIONS OF FUNGICIDAL AZOLES AND PYRION COMPOUNDS BOSSELAERS JAN PETER HENDRIK 2010-12-02 US disclosed
US-7662748-B2 Such as azaconazole, bromuconazole, and N,N',N'-tris(2-hydroxyethyl)-N-cocoalkyl-1,3-diamino-propane; kits; for protection of crops, plants, fruits, seeds, wood products, thatch, biodegradable material and textiles JANSSEN PHARMACEUTICA, N.V. (BE) 2010-02-16 US disclosed
US-20050080089-A1 Formulations comprising triazoles and alkoxylated amines AKZO NOBEL CHEMICALS BV (NL) 2005-04-14 US disclosed
EP-1473996-A1 FORMULATIONS COMPRISING TRIAZOLES AND ALKOXYLATED AMINES JANSSEN PHARMACEUTICA N.V. (BE) 2004-11-10 EP disclosed
WO-2003065807-A1 FORMULATIONS COMPRISING TRIAZOLES AND ALKOXYLATED AMINES JANSSEN PHARMACEUTICA N.V. (BE) 2003-08-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050080089-A1 Formulations comprising triazoles and alkoxylated amines ALKBH3, TYR, NAT1 TDO2 35/4885IDO2 24/4885IDO1 10/4885
US-20100305161-A1 COMBINATIONS OF FUNGICIDAL AZOLES AND PYRION COMPOUNDS PPOX, PNPO, CYP3A43 TDO2 46/4885IDO2 33/4885IDO1 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.